249 related articles for article (PubMed ID: 38182712)
1. Transcriptome-based biomarker prediction for Parkinson's disease using genome-scale metabolic modeling.
Abdik E; Çakır T
Sci Rep; 2024 Jan; 14(1):585. PubMed ID: 38182712
[TBL] [Abstract][Full Text] [Related]
2. Systematic investigation of mouse models of Parkinson's disease by transcriptome mapping on a brain-specific genome-scale metabolic network.
Abdik E; Çakır T
Mol Omics; 2021 Aug; 17(4):492-502. PubMed ID: 34370801
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
Xin G; Niu J; Tian Q; Fu Y; Chen L; Yi T; Tian K; Sun X; Wang N; Wang J; Zhang H; Wang L
PLoS One; 2023; 18(12):e0294984. PubMed ID: 38051734
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
5. Coordinated modification in expression levels of HSPA1A/B, DGKH, and NOTCH2 in Parkinson's patients' blood and substantia nigra as a diagnostic sign: the transcriptomes' relationship.
Asad Samani L; Ghaedi K; Majd A; Peymani M; Etemadifar M
Neurol Sci; 2023 Aug; 44(8):2753-2761. PubMed ID: 36973590
[TBL] [Abstract][Full Text] [Related]
6. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
7. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease.
Glaab E; Schneider R
Neurobiol Dis; 2015 Feb; 74():1-13. PubMed ID: 25447234
[TBL] [Abstract][Full Text] [Related]
8. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.
Li X; Fan X; Yang H; Liu Y
Mol Neurobiol; 2022 Feb; 59(2):1041-1057. PubMed ID: 34826053
[TBL] [Abstract][Full Text] [Related]
9. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
[TBL] [Abstract][Full Text] [Related]
10. Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression.
Krokidis MG; Exarchos TP; Vlamos P
Math Biosci Eng; 2021 Feb; 18(2):1813-1832. PubMed ID: 33757212
[TBL] [Abstract][Full Text] [Related]
11. Brain-wide transcriptome-based metabolic alterations in Parkinson's disease: human inter-region and human-experimental model correlations.
Odongo R; Bellur O; Abdik E; Çakır T
Mol Omics; 2023 Aug; 19(7):522-537. PubMed ID: 36928892
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of Parkinson's disease: present and future.
Miller DB; O'Callaghan JP
Metabolism; 2015 Mar; 64(3 Suppl 1):S40-6. PubMed ID: 25510818
[TBL] [Abstract][Full Text] [Related]
13. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
14. [Identification of people at the latent stage of Parkinson's disease (the PARKINLAR study): first results and an optimization of the algorithm].
Fedotova EY; Chechetkin AO; Abramycheva NY; Chigaleychik LA; Baziyan BK; Ponomareva ТА; Alexeeva NS; Fedin PA; Kravchenko MA; Varakin YY; Ivanova-Smolenskaya IA; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):4-11. PubMed ID: 26356391
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential diagnostic biomarkers for Parkinson's disease.
Jiang F; Wu Q; Sun S; Bi G; Guo L
FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
[TBL] [Abstract][Full Text] [Related]
17. LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease.
Taghizadeh E; Gheibihayat SM; Taheri F; Afshani SM; Farahani N; Saberi A
Neurol Sci; 2021 Oct; 42(10):4007-4015. PubMed ID: 34254198
[TBL] [Abstract][Full Text] [Related]
18. Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson's Disease.
Zhang W; Shen J; Wang Y; Cai K; Zhang Q; Cao M
Front Mol Neurosci; 2022; 15():762544. PubMed ID: 35310885
[TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis related biomarkers and immune infiltration in Parkinson's disease by integrated bioinformatic analysis.
Xing N; Dong Z; Wu Q; Zhang Y; Kan P; Han Y; Cheng X; Wang Y; Zhang B
BMC Med Genomics; 2023 Mar; 16(1):55. PubMed ID: 36918862
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
